APOE and Alzheimer disease: We have previously shown that detecting Alzheimer's disease pathology among cognitively normal individuals can be achieved using models incorporating age, sex and APOE4 carriership (AUC 0.82) (155) and that this can be increased further (AUC 0.84), for example by adding body mass index, a proxy for insulin resistance (151).